Technology
Health
Pharmaceutical

Cassava Sciences

$1.24
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.05 (4.19%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell SAVA and other stocks, options, ETFs, and crypto commission-free!

About SAVA

Cassava Sciences, Inc. engages in the development of novel drugs. It focuses on developing product candidates intended for the treatment of Alzheimer's disease, including PTI-125 and PTI-125Dx. Read More The company was founded by Remi Barbier and Barry M. Sherman in May 1998 and is headquartered in Austin, TX.

Employees
9
Headquarters
Austin, Texas
Founded
1998
Market Cap
21.35M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
263.63K
High Today
$1.25
Low Today
$1.18
Open Price
$1.18
Volume
121.52K
52 Week High
$2.99
52 Week Low
$0.76

Collections

Technology
Health
Pharmaceutical
US
North America

SAVA Earnings

-$0.37
-$0.26
-$0.15
-$0.04
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
-$0.06 per share
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.